急性缺血性卒中静脉溶栓潜在错过机会分析
本研究为BEST-MSU试验的次要观察性队列分析,纳入1515例确诊急性缺血性卒中且无静脉溶栓禁忌症的患者,比较移动卒中单元(MSU)与急诊科管理。结果显示急诊科组潜在错过静脉溶栓机会为12.6%,MSU组仅0.7%;错过机会与较低NIHSS评分和较长发病至到院时间独立相关,且39%错过机会的患者3个月功能预后不良。
要点
- 急诊科管理中约1/8符合条件患者潜在错过静脉溶栓,MSU可大幅降低此风险
- 较低NIHSS评分和较长发病至到院时间与潜在错过静脉溶栓独立相关
- 即使因症状改善或轻微缺损未溶栓,超1/3患者3个月功能预后不良
核心结论
- 在BEST-MSU试验中,急诊科管理的急性缺血性卒中患者约1/8存在潜在错过静脉溶栓机会,而MSU管理中极少发生。
研究设计与样本
- BEST-MSU试验的次要观察性队列分析,前瞻性、多中心,2014至2020年在美国7个城市比较MSU与标准急诊科管理。
- 分析队列为1515例入组患者中927例确诊急性缺血性卒中且无静脉溶栓指南禁忌症者。
主要发现
- 51例(5.5%)存在潜在错过静脉溶栓机会,MSU组4/555(0.7%),急诊科组47/372(12.6%),比值比0.05(95%CI 0.02-0.12)。
- 多变量分析中,较低NIHSS评分(比值比0.95,95%CI 0.90-0.99)和较长发病至到院时间(每10分钟比值比1.08,95%CI 1.03-1.13)与潜在错过机会独立相关。
- 未溶栓的主要记录原因包括症状缓解(43%)、时间窗顾虑(18%)和轻微缺损(10%)。
- 在49例有3个月改良Rankin量表记录的潜在错过机会患者中,19例(39%)评分为3至6分。
临床怎么用
- 急诊科应优化流程以减少符合条件患者的静脉溶栓错过,尤其关注低NIHSS评分和到院延迟者。
- 对症状缓解或轻微缺损患者仍需谨慎评估,因部分患者3个月功能预后不良。
局限性
- 本研究为BEST-MSU试验的次要观察性分析,可能存在未测量混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent years have seen improvements in stroke-care pathways, including mobile stroke units (MSUs), and this may have affected the rate, predictors, and outcomes of patients with acute ischemic stroke who qualify for but do not receive treatment with intravenous thrombolysis (IVT). METHODS: This was a secondary observational cohort analysis of the prospective, multicenter BEST-MSU trial (Benefits of Stroke Treatment Delivered by a Mobile Stroke Unit Compared With Standard Management by Emergency Medical Services), conducted in 7 US cities from 2014 to 2020, comparing MSU management versus standard emergency department management for patients with suspected acute ischemic stroke. The analytical cohort comprised enrolled patients with confirmed acute ischemic stroke and no guideline contraindications to IVT. The outcome was a potential missed IVT opportunity, defined as patients not treated with IVT despite lacking contraindications. We used multivariable logistic regression to evaluate whether demographics, prestroke modified Rankin Scale, study site, comorbidities, National Institutes of Health Stroke Scale, blood pressure, international normalized ratio, glucose, antithrombotic use, and thrombectomy were associated with this outcome. RESULTS: Of 1515 enrolled patients, 927 met criteria for this analysis. Fifty-one participants (5.5%) had a potential missed IVT opportunity, including 4 of 555 (0.7%) in the MSU group versus 47 of 372 (12.6%) in the emergency department group (odds ratio, 0.05 [95% CI, 0.02-0.12]). In multivariable analysis, omitting study group, lower National Institutes of Health Stroke Scale (odds ratio, 0.95 [95% CI, 0.90-0.99]) and longer last known well-to-door time (odds ratio per 10 minutes, 1.08 [95% CI, 1.03-1.13]) were independently associated with a potential missed IVT opportunity. The leading reasons documented for withholding IVT were resolving symptoms (43%), time window concerns (18%), and minor deficits (10%). Among participants with a potential missed IVT opportunity and a recorded 3-month modified Rankin Scale (n=49), 19 (39%) had a score of 3 to 6. CONCLUSIONS: In the BEST-MSU trial, potential missed IVT opportunities occurred in 1-in-8 patients in the emergency department, and rarely on the MSU. Although often due to early improvement or minor deficits, more than one-third of these patients had poor functional status at 3 months. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02190500.
引用
- Navi BB, Wang M, Yamal JM, et al. Potential Missed Opportunities to Administer Intravenous Thrombolysis to Patients With Acute Ischemic Stroke. Stroke. 2026. PMID: 41608799. doi:10.1161/STROKEAHA.125.054326
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。